美国与英国痴呆发病前的衰弱轨迹
研究基于4项前瞻性队列(英国老龄化纵向研究、健康与退休研究、拉什记忆与老化项目、美国国家阿尔茨海默病协调中心),纳入60岁及以上基线无认知障碍者29849人(平均年龄71.6岁,女性18369人,随访257963人年,痴呆发病3154例)。贝叶斯广义线性混合回归显示痴呆发病前4至9年衰弱轨迹加速,衰弱与痴呆风险正相关(aHR范围1.18至1.73)。作者认为衰弱测量或可用于筛选痴呆预防临床试验的高风险人群。
要点
- 痴呆发病前4至9年衰弱轨迹出现加速。
- 衰弱与痴呆风险正相关,aHR范围1.18至1.73。
- 作者认为衰弱测量或可用于筛选痴呆预防试验的高风险人群。
核心结论
- 这些发现提示衰弱测量或可用于识别痴呆预防与治疗临床试验优先入组的高风险人群。
- 衰弱本身可能成为行为与社会层面痴呆预防的上游靶点。
研究设计与样本
- 研究数据来自4项前瞻性队列研究:英国老龄化纵向研究、健康与退休研究、拉什记忆与老化项目、美国国家阿尔茨海默病协调中心。
- 数据收集于1997年至2024年,分析于2023年7月至2024年8月,研究场景为退休社区、全国性调查和多诊所队列。
- 纳入标准为60岁及以上、基线无认知障碍,且有年龄、性别、教育水平、族裔数据及基线计算的衰弱指数评分。
- 排除前参与者为87737人,排除后分析29849人(平均[SD]年龄71.6[7.7]岁;女性18369人[62%];随访257963人年;痴呆发病3154例)。
主要发现
- 贝叶斯广义线性混合回归模型显示痴呆发病前4至9年衰弱轨迹出现加速。
- 总体衰弱与痴呆风险正相关(aHR范围1.18;95%CI 1.13-1.24至1.73;95%CI 1.57-1.92)。
- 在衰弱测量与痴呆发病间隔超过所识别加速期的参与者中,该关联依然存在(aHR范围1.18;95%CI 1.12-1.23至1.43;95%CI 1.14-1.80)。
临床怎么用
- 作者认为衰弱测量或可用于识别痴呆预防与治疗临床试验优先入组的高风险人群。
- 作者认为衰弱本身可能成为行为与社会层面痴呆预防的上游靶点。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: An accessible marker of both biological age and dementia risk is crucial to advancing dementia prevention and treatment strategies. Although frailty is a candidate for that role, the nature of the relationship between frailty and dementia is not well understood. OBJECTIVE: To clarify the temporal relationship between frailty and incident dementia by investigating frailty trajectories in the years preceding dementia onset. DESIGN, SETTING, AND PARTICIPANTS: Participant data came from 4 prospective cohort studies: the English Longitudinal Study of Ageing, the Health and Retirement Study, the Rush Memory and Aging Project, and the National Alzheimer Coordinating Center. Data were collected between 1997 and 2024 and were analyzed from July 2023 to August 2024. The settings were retirement communities, national-level surveys, and a multiclinic-based cohort. Included individuals were 60 years or older and without cognitive impairment at baseline. Included individuals also had data on age, sex, education level, and ethnicity and a frailty index score calculated at baseline. EXPOSURE: Frailty was the main exposure, with participants' degrees of frailty quantified using retrospectively calculated frailty index scores. MAIN OUTCOMES AND MEASURES: Incident all-cause dementia ascertained through physician-derived diagnoses, self- and informant-report, and estimated classifications based on combinations of cognitive tests. RESULTS: The participant number before exclusions was 87 737. After exclusions, data from 29 849 participants (mean [SD] age, 71.6 [7.7] years; 18 369 female [62%]; 257 963 person-years of follow-up; 3154 cases of incident dementia) were analyzed. Bayesian generalized linear mixed regression models revealed accelerations in frailty trajectories 4 to 9 years before incident dementia. Overall, frailty was positively associated with dementia risk (adjusted hazard ratios [aHRs] ranged from 1.18; 95% CI, 1.13-1.24 to 1.73; 95% CI, 1.57-1.92). This association held among participants whose time between frailty measurement and incident dementia exceeded the identified acceleration period (aHRs ranged from 1.18; 95% CI, 1.12-1.23 to 1.43; 95% CI, 1.14-1.80). CONCLUSIONS AND RELEVANCE: These findings suggest that frailty measurements may be used to identify high-risk population groups for preferential enrolment into clinical trials for dementia prevention and treatment. Frailty itself may represent a useful upstream target for behavioral and societal approaches to dementia prevention.
引用
- Ward DD, Flint JP, Littlejohns TJ, et al. Frailty Trajectories Preceding Dementia in the US and UK. JAMA Neurol. 2025. PMID: 39527039. doi:10.1001/jamaneurol.2024.3774
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。